Wagner Paul A.

CIK 00016128422 companiesDALLAS, TX

SEC Profile

Transactions

Companies

Filings

CIK

0001612842

Recent Transactions

50 trades

Award
Forte Biosciences, Inc.$FBRX
Stock Option (right to buy)
2026-01-12+270,000→ 270,000 total
Award
Forte Biosciences, Inc.$FBRX
Restricted Stock Units
2026-01-12+180,000→ 180,000 total
Exercise/Conversion
Forte Biosciences, Inc.$FBRX
Common Stock
2026-01-01+1,250→ 83,342 total
Exercise/Conversion
Forte Biosciences, Inc.$FBRX
Restricted Stock Units
2026-01-01−1,250→ 5,000 total
Tax Payment
Forte Biosciences, Inc.$FBRX
Common Stock
2026-01-01$27.27/sh−164→ 83,178 total
Tax Payment
Forte Biosciences, Inc.$FBRX
Common Stock
2025-10-01$14.52/sh−98→ 82,092 total
Exercise/Conversion
Forte Biosciences, Inc.$FBRX
Common Stock
2025-10-01+1,250→ 82,190 total
Exercise/Conversion
Forte Biosciences, Inc.$FBRX
Restricted Stock Units
2025-10-01−1,250→ 6,250 total
Tax Payment
Forte Biosciences, Inc.$FBRX
Common Stock
2025-07-01$12.44/sh−98→ 80,940 total
Exercise/Conversion
Forte Biosciences, Inc.$FBRX
Common Stock
2025-07-01+1,250→ 81,038 total
Exercise/Conversion
Forte Biosciences, Inc.$FBRX
Restricted Stock Units
2025-07-01−1,250→ 7,500 total
Tax Payment
Forte Biosciences, Inc.$FBRX
Common Stock
2025-04-01$7.43/sh−18→ 79,788 total
Exercise/Conversion
Forte Biosciences, Inc.$FBRX
Restricted Stock Units
2025-04-01−1,250→ 8,750 total
Exercise/Conversion
Forte Biosciences, Inc.$FBRX
Common Stock
2025-04-01+1,250→ 79,806 total
Award
Forte Biosciences, Inc.$FBRX
Stock Option (right to buy)
2025-03-20+920,000→ 920,000 total
Tax Payment
Forte Biosciences, Inc.$FBRX
Common Stock
2025-01-01$22.71/sh−164→ 78,556 total
Exercise/Conversion
Forte Biosciences, Inc.$FBRX
Restricted Stock Units
2025-01-01−1,250→ 10,000 total
Exercise/Conversion
Forte Biosciences, Inc.$FBRX
Common Stock
2025-01-01+1,250→ 78,720 total
Tax Payment
Forte Biosciences, Inc.$FBRX
Common Stock
2024-10-01$5.16/sh−98→ 77,470 total
Exercise/Conversion
Forte Biosciences, Inc.$FBRX
Common Stock
2024-10-01+1,250→ 77,568 total
Exercise/Conversion
Forte Biosciences, Inc.$FBRX
Restricted Stock Units
2024-10-01−1,250→ 11,250 total
Tax Payment
Forte Biosciences, Inc.$FBRX
Common Stock
2024-07-01$0.55/sh−2,453→ 1,907,971 total
Exercise/Conversion
Forte Biosciences, Inc.$FBRX
Restricted Stock Units
2024-07-01−31,250→ 312,500 total
Exercise/Conversion
Forte Biosciences, Inc.$FBRX
Common Stock
2024-07-01+31,250→ 1,910,424 total
Exercise/Conversion
Forte Biosciences, Inc.$FBRX
Common Stock
2024-04-01+31,250→ 1,881,627 total
Exercise/Conversion
Forte Biosciences, Inc.$FBRX
Restricted Stock Units
2024-04-01−31,250→ 343,750 total
Tax Payment
Forte Biosciences, Inc.$FBRX
Common Stock
2024-04-01$0.71/sh−2,453→ 1,879,174 total
Award
Forte Biosciences, Inc.$FBRX
Stock Option (right to buy)
2024-03-21+1,100,000→ 1,100,000 total
Tax Payment
Forte Biosciences, Inc.$FBRX
Common Stock
2024-01-01$0.82/sh−4,109→ 1,850,377 total
Exercise/Conversion
Forte Biosciences, Inc.$FBRX
Common Stock
2024-01-01+31,250→ 1,854,486 total
Exercise/Conversion
Forte Biosciences, Inc.$FBRX
Restricted Stock Units
2024-01-01−31,250→ 375,000 total
Purchase
Forte Biosciences, Inc.$FBRX
Common Stock
2023-12-18$0.75/sh+10,000→ 1,823,236 total
Purchase
Forte Biosciences, Inc.$FBRX
Common Stock
2023-12-14$0.72/sh+10,000→ 1,813,236 total
Purchase
Forte Biosciences, Inc.$FBRX
Common Stock
2023-12-13$0.70/sh+10,520→ 1,803,236 total
Purchase
Forte Biosciences, Inc.$FBRX
Common Stock
2023-12-12$0.65/sh+4,776→ 1,792,716 total
Purchase
Forte Biosciences, Inc.$FBRX
Common Stock
2023-12-11$0.65/sh+25,000→ 1,787,940 total
Purchase
Forte Biosciences, Inc.$FBRX
Common Stock
2023-12-08$0.62/sh+15,000→ 1,762,940 total
Purchase
Forte Biosciences, Inc.$FBRX
Common Stock
2023-12-07$0.58/sh+36,203→ 1,747,940 total
Purchase
Forte Biosciences, Inc.$FBRX
Common Stock
2023-11-22$0.43/sh+400→ 1,711,737 total
Purchase
Forte Biosciences, Inc.$FBRX
Common Stock
2023-11-20$0.43/sh+1,566→ 1,711,237 total
Purchase
Forte Biosciences, Inc.$FBRX
Common Stock
2023-11-20$0.43/sh+100→ 1,711,337 total
Purchase
Forte Biosciences, Inc.$FBRX
Common Stock
2023-11-20$0.44/sh+5,300→ 1,709,671 total
Tax Payment
Forte Biosciences, Inc.$FBRX
Common Stock
2023-10-01$0.66/sh−2,453→ 1,704,371 total
Exercise/Conversion
Forte Biosciences, Inc.$FBRX
Common Stock
2023-10-01+31,250→ 1,706,824 total
Exercise/Conversion
Forte Biosciences, Inc.$FBRX
Restricted Stock Units
2023-10-01−31,250→ 406,250 total
Award
Forte Biosciences, Inc.$FBRX
Common Stock
2023-07-31$1.01/sh+247,524→ 1,675,574 total
Exercise/Conversion
Forte Biosciences, Inc.$FBRX
Common Stock
2023-07-01+31,250→ 1,430,503 total
Tax Payment
Forte Biosciences, Inc.$FBRX
Common Stock
2023-07-01$1.04/sh−2,453→ 1,428,050 total
Exercise/Conversion
Forte Biosciences, Inc.$FBRX
Restricted Stock Units
2023-07-01−31,250→ 437,500 total
Exercise/Conversion
Forte Biosciences, Inc.$FBRX
Restricted Stock Units
2023-04-01−31,250→ 468,750 total

Companies

Recent Filings

Address

C/O FORTE BIOSCIENCES, INC. 3060 PEGASUS PARK DR., BLDG 6

DALLAS, TX, 75247

View on SEC.gov